Journal List > Ann Clin Microbiol > v.16(3) > 1078471

TOOLS
Lim, Lee, Seo, Yum, Yong, Lee, and Chong: Loss of blaVIM-2 and blaIMP-1 during the Storage of Gram-Negative Bacilli, Antimicrobial Susceptibility of the Gene-Lost Strain, and Location of the Gene in the Cell
Original Article

Ann Clin Microbiol 2013;16(3):120-125.

Published online: 5 December 2013

DOI: https://doi.org/10.5145/ACM.2013.16.3.120

Loss of blaVIM-2 and blaIMP-1 during the Storage of Gram-Negative Bacilli, Antimicrobial Susceptibility of the Gene-Lost Strain, and Location of the Gene in the Cell

Youngsik Lim1, Yangsoon Lee1, 2, Younghee Seo1, Jong Hwa Yum3, Dongeun Yong1, Kyungwon Lee1, Yunsop Chong1

1Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, Seoul, Korea

2Department of Laboratory Medicine, National Health Insurance Corporation Ilsan Hospital, Goyang, Korea

3Department of Clinical Laboratory Science, Dong-eui University, Busan, Korea

Correspondence: Kyungwon Lee, Department of Laboratory Medicine and Research Institute of Bacterial Resistance, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea. (Tel) 82-2-2228-2446, (Fax) 82-2-313-0908, (E-mail) leekcp@yuhs.ac

Received 20 February 20138 March 2013       Accepted 8 March 2013

Copyright © 2013 The Korean Society of Clinical Microbiology

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

초록

Background

Gram-negative bacilli can be stored in cystine tryptic agar (CTA) at room temperature for over 1 year, but we experienced a loss of imipenem resistance among VIM-2-producing isolates. The aims of this study were to determine the frequency of loss of IMP-1 and VIM-2 genes during storage in CTA at room temperature and to document any change in the MIC of antimicrobial agents and the location of the gene.

Methods

Bacteria were isolated from clinical specimens at Severance Hospital collected from 1995-2000. Modified Hodge and double disk synergy tests were performed for screening of MBL-production isolates, and blaIMP-1 and blaVIM-2 were detected by PCR. Loss of resistance was tested in CTA at room temperature. PFGE and hybridization using a blaVIM-2 probe were carried out to determine the location of the VIM-2 gene.

Results

When VIM-2- and IMP-1-producing strains of eight P. aeruginosa and two Acinetobacter spp. were stored in CTA at room temperature, some isolates lost imipenem resistance after 3 days and 90% lost resistance after 15 weeks. Loss of resistance genes resulted in a decrease of the MIC of imipenem from 32-128 μ g/mL to 0.5-8 μ g/mL for P. aeruginosa, and from 32 μ g/mL to 0.25-4 μ g/mL for Acinetobacter spp. Hybridization of I-Ceu I and S1-digested and PFGE suggested that VIM-2 genes are located on approximately 50-100 kb or 400 kb plasmids.

Conclusion

Isolates may lose resistance genes when stored in CTA at room temperature. Therefore, it is necessary for MBL-production tests including the Modified Hodge test and double disk synergy test and detection of MBL genes.

Keywords: Carbapenems, Metallo-β-lactamase, Resistance loss

REFERENCES

1.Livingstone D., Gill MJ., Wise R. Mechanisms of resistance to the carbapenems. J Antimicrob Chemother. 1995. 35:1–5.
crossref
2.Lee K., Lim JB., Yum JH., Yong D., Chong Y., Kim JM, et al. bla VIM-2 cassette-containing novel integrons in metallo-beta-lacta-mase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital. Antimicrob Agents Chemother. 2002. 46:1053–8.
3.Lee K., Park AJ., Kim MY., Lee HJ., Cho JH., Kang JO, et al. KONSAR Group. Metallo-beta-lactamase-producing Pseudomonas spp. in Korea: high prevalence of isolates with VIM-2 type and emergence of isolates with IMP-1 type. Yonsei Med J. 2009. 50:335–9.
4.Dale J. Extrachromosomal Inheritance. In. Dale JW, editor. Molecular Genetics of Bacteria. 2nd ed. Chichester, England: John Wiley & Sons;1994. p. 133–61.
5.Takahashi A., Yomoda S., Kobayashi I., Okubo T., Tsunoda M., Iyobe S. Detection of carbapenemase-producing Acinetobacter baumannii in a hospital. J Clin Microbiol. 2000. 38:526–9.
6.Lim Y. Yong D, Yum JH, Lee K, Chong Y. Difficulties in the detection of resistance gene and the determination of imipenem resistance of the metallo-beta-lactamase producing gram-negative bacilli. 42nd Intersci Conf Antimicrob Agents Chemother Abstr. 2002. D-530:139.
7.Arakawa Y., Murakami M., Suzuki K., Ito H., Wacharotayankun R., Ohsuka S, et al. A novel integron-like element carrying the metallo- beta-lactamase gene bla IMP. Antimicrob Agents Chemother. 1995. 39:1612–5.
8.Poirel L., Naas T., Nicolas D., Collet L., Bellais S., Cavallo JD, et al. Characterization of VIM-2, a carbapenem-hydrolyzing metallo- beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother. 2000. 44:891–7.
9.Yum JH., Yi K., Lee H., Yong D., Lee K., Kim JM, et al. Molecular characterization of metallo-beta-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the bla VIM-2 gene cassettes. J Antimicrob Chemother. 2002. 49:837–40.
10.Yum JH., Yong D., Lee K., Kim HS., Chong Y. A new integron carrying VIM-2 metallo-beta-lactamase gene cassette in a Serratia marcescens isolate. Diagn Microbiol Infect Dis. 2002. 42:217–9.
11.Jeong SH., Lee K., Chong Y., Yum JH., Lee SH., Choi HJ, et al. Characterization of a new integron containing VIM-2, a metallo- beta-lactamase gene cassette, in a clinical isolate of Enterobacter cloacae. J Antimicrob Chemother. 2003. 51:397–400.
12.Clinical and Laboratory Standards Institute. Performance Standard for Antimicrobial Susceptibility Testing; Twenty Informational Supplement; Approved Guidelind. Document M100-S14. Wayne, PA; Clinical and Laboratory Standards Institute. 2004.
13.Lee K., Lim YS., Yong D., Yum JH., Chong Y. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-beta-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol. 2003. 41:4623–9.
14.Lee K., Chong Y., Shin HB., Kim YA., Yong D., Yum JH. Modified Hodge and EDTA-disk synergy tests to screen metallo-beta-lacta-mase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect. 2001. 7:88–91.
15.Riccio ML., Franceschini N., Boschi L., Caravelli B., Cornaglia G., Fontana R, et al. Characterization of the metallo-beta-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of bla IMP allelic variants carried by gene cassettes of different phylogeny. Antimicrob Agents Chemother. 2000. 44:1229–35.
16.Sambrook J., Russell D. Molecular Cloning: A Laboratory Ma-nual. 3rd ed. Cold Spring Harbor (NY); Cold Spring Harbor Laboratory Press. 2001.
17.Köhler T., Pechère C. In vitro selection of antibiotic resistance in Pseudomonas aeruginosa. Clin Microbiol Infect. 2001. 7(S):7–10.
18.Doménech-Sánchez A., Martínez-Martínez L., Hernández-Allés S., del Carmen Conejo M., Pascual A., Tomás JM, et al. Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance. Antimicrob Agents Chemother. 2003. 47:3332–5.
19.Livermore DM., Woodford N. Carbapenemases: a problem in wai-ting? Curr Opin Microbiol. 2000. 3:489–95.
crossref

Fig. 1.
Pulsed field gel electropho-resis of whole genomic DNA of P. aeruginosa isolates digested with I- Ceu I (A), and S1 nuclease (D). Sou-thern blot hybridization with 16S rRNA gene probes (B) and bla VIM-2 gene probe (C and E). Lanes 1 to 8, whole genomic DNA from isolates no. 1-3, 6-9 and 12 P. aeruginosa; lane M, lambda ladder (Bio-Rad) as a marker (kb).
acm-16-120f1.tif
Table 1.
Detection of cells with partial or complete loss of MBL gene during storage in CTA tubes at room temperature∗
Organism (No. of isolates tested) MBL gene　 No. of isolates which lost MBL gene
Partial† Complete Total
P. aeruginosa (54) bla VIM-2 15 4 19 (35.1)
P. putida (10) bla VIM-2 1 0 1 (10.0)
Acinetobacter spp. (16) bla VIM-2 1 0 1 (6.3)
Acinetobacter spp. (4) bla IMP-1 1 0 1 (25.0)
Total (84) 　 18 4 22 (26.1)

∗ Storage time was approximately 4-12 months depending on iso-late;

† Isolates which lost partially MBL gene showed heterogeneous growth within the zone of inhibition in disk diffusion test using imipenem.

Table 2.
Proportion of cells which lost imipenem resistance during storage in CTA tubes at room temperature
Isolate no. Species MBL type Colonies (%) with loss of resistance at∗
3 days 1 week 2 week 4 week 15 week
1 P. aeruginosa VIM-2 3 6 7 11 28
2 P. aeruginosa VIM-2 0 0 2 9 9
3 P. aeruginosa VIM-2 0 0 1 15 92
6 P. aeruginosa VIM-2 5 18 6 15 20
7 P. aeruginosa VIM-2 1 11 5 7 19
8 P. aeruginosa VIM-2 0 0 0 1 2
9 P. aeruginosa VIM-2 0 0 0 0 1
12 P. aeruginosa VIM-2 0 0 0 0 0
13 A. baumannii VIM-2 1 3 3 5 33
5 A. baumannii IMP-1 0 8 5 8 55

∗ One hundred colonies were tested for each isolate.

Table 3.
Comparison of MICs of antimicrobial agents for MBL-gene positive isolates and MBL-gene lost counterpart strains
Antimicrobial agents MBL gene MIC (μ g/mL) for:
P. aeru ACI
1 2 3 6 7 8 9 12 13 5
IMP Positive 64 128 128 32 128 32 32 32 32 32
Negative 4 8 0.5 0.5 0.5 1 1 2 4 0.25
MER Positive 16 ＞128 ＞128 8 ＞128 32 32 8 16 32
Negative 0.5 NT 8 1 8 1 0.5 0.5 4 0.5
PIP Positive 128 ＞256 256 ＞256 ＞256 ＞256 256 64 256 256
Negative 2 NT ＞256 256 ＞256 16 8 64 256 32
CAZ Positive ＞128 128 ＞128 128 128 ＞128 128 64 64 128
Negative 2 NT 4 4 4 4 2 16 16 4
CAZ-CLV Positive ＞128 128 ＞128 128 128 ＞128 128 64 64 128
Negative 2 NT 4 4 4 4 4 16 8 4
CTX Positive ＞128 ＞128 ＞128 ＞128 ＞128 ＞128 ＞128 ＞128 ＞128 ＞128
Negative 16 NT 32 64 32 32 16 64 16 16
FEP Positive 64 64 64 64 32 64 64 32 16 128
Negative 8 NT 8 16 16 16 16 16 8 8
AZT Positive 16 32 16 16 16 16 8 32 8 4
Negative 4 NT 16 16 16 16 8 32 16 4

Abbreviations: ACI, Acinetobacter spp.; IMP, imipenem; MER, meropenem; PIP, pipracillin; CAZ, ceftazidime; CAZ-CLV, ceftazidime-clavulanic acid; CTX, cefotaxim; FEP, cefepim; AZT, aztreonam; NT, not tested.

TOOLS
Similar articles